Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Zejula 100mg capsules
0801050CJBBAAAA
|
Zejula | Niraparib | Malignant Disease and Immunosuppression | No data available |
|
Zelboraf 240mg tablets
0801050BDBBAAAA
|
Zelboraf | Vemurafenib | Malignant Disease and Immunosuppression | No data available |
|
Zeldox 60mg capsules
0402010AGBBACAC
|
Zeldox | Ziprasidone hydrochloride | Central Nervous System | No data available |
|
Zeldox 80mg capsules
0402010AGBBABAB
|
Zeldox | Ziprasidone hydrochloride | Central Nervous System | No data available |
|
Zemon 60 XL tablets
0206010K0CEAAAE
|
Zemon | Isosorbide mononitrate | Cardiovascular System | No data available |
|
Zemplar 10micrograms/2ml solution for injection ampoules
0906040P0BBABAB
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 2microgram capsules
0906040P0BBADAD
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 4microgram capsules
0906040P0BBAEAE
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 5micrograms/1ml solution for injection ampoules
0906040P0BBAAAA
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zemplar 5micrograms/1ml solution for injection vials
0906040P0BBAFAF
|
Zemplar | Paricalcitol | Nutrition and Blood | No data available |
|
Zenalb 20% solution for infusion 100ml bottles
0902022A0BBABAC
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
|
Zenalb 20% solution for infusion 50ml bottles
0902022A0BBAAAB
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
|
Zenalb 4.5% solution for infusion 100ml bottles
0902022A0BBAFAE
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
|
Zenalb 4.5% solution for infusion 250ml bottles
0902022A0BBACAF
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
|
Zenalb 4.5% solution for infusion 500ml bottles
0902022A0BBADAG
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
|
Zenalb 4.5% solution for infusion 50ml bottles
0902022A0BBAEAK
|
Zenalb | Albumin solution | Nutrition and Blood | No data available |
|
Zenapax 25mg/5ml solution for infusion vials
0802020V0BBAAAA
|
Zenapax | Daclizumab | Malignant Disease and Immunosuppression | No data available |
|
Zenoxone 1% cream
1304000V0BFAAAD
|
Zenoxone | Hydrocortisone | Skin | No data available |
|
ZenSetiv hydrocolloid mouldable ring 100mm (2.5mm)
23850958502
|
ZenSetiv hydrocolloid mouldable ring 100mm (2.5mm) | Skin Protectors | Stoma Appliances | No data available |
|
ZenSetiv hydrocolloid mouldable ring 50mm (2.5mm)
23850958500
|
ZenSetiv hydrocolloid mouldable ring 50mm (2.5mm) | Skin Protectors | Stoma Appliances | No data available |
|
ZenSetiv hydrocolloid mouldable ring 50mm (4mm)
23850958501
|
ZenSetiv hydrocolloid mouldable ring 50mm (4mm) | Skin Protectors | Stoma Appliances | No data available |
|
ZenSiv colostomy bag with filter and vent 25mm
23350953501
|
ZenSiv colostomy bag with filter and vent 25mm | Colostomy Bags | Stoma Appliances | No data available |
|
ZenSiv colostomy bag with filter and vent 32mm
23350953502
|
ZenSiv colostomy bag with filter and vent 32mm | Colostomy Bags | Stoma Appliances | No data available |
|
ZenSiv colostomy bag with filter and vent 38mm
23350953503
|
ZenSiv colostomy bag with filter and vent 38mm | Colostomy Bags | Stoma Appliances | No data available |
|
ZenSiv colostomy bag with filter, mini 10-50mm
23350953504
|
ZenSiv colostomy bag with filter, mini 10-50mm | Colostomy Bags | Stoma Appliances | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.